ADC Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADCT and other ETFs, options, and stocks.About ADCT
ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602.
CEOAmeet Mallik
CEOAmeet Mallik
Employees265
Employees265
HeadquartersEpalinges, Vaud
HeadquartersEpalinges, Vaud
Founded2011
Founded2011
Employees265
Employees265
ADCT Key Statistics
Market cap450.00M
Market cap450.00M
Price-Earnings ratio-2.55
Price-Earnings ratio-2.55
Dividend yield—
Dividend yield—
Average volume686.02K
Average volume686.02K
High today$4.08
High today$4.08
Low today$3.88
Low today$3.88
Open price$4.00
Open price$4.00
Volume1.27M
Volume1.27M
52 Week high$4.80
52 Week high$4.80
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
ADC Therapeutics(ADCT) stock is priced at $4.01, giving the company a market capitalization of 450M. It carries a P/E multiple of -2.55.
During the trading session on 2025-11-06, ADC Therapeutics(ADCT) shares reached a daily high of $4.08 and a low of $3.88. At a current price of $4.01, the stock is +3.4% higher than the low and still -1.7% under the high.
Trading activity shows a volume of 1.27M, compared to an average daily volume of 686.02K.
Over the past 52 weeks, ADC Therapeutics(ADCT) stock has traded between a high of $4.80 and a low of $1.05.
Over the past 52 weeks, ADC Therapeutics(ADCT) stock has traded between a high of $4.80 and a low of $1.05.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ADCT. This list is generated using Robinhood data, and it’s not a recommendation.